GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Weight loss and diabetes control are life-changing benefits of these medications but eye health should not be overlooked. As researchers continue to investigate, staying informed and proactive can ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

It can also increase the risk of serious eye ... are prescribed to Type 2 diabetes patients on the NHS. However, Ms Myerscough's weight loss of six stone in one year, and eight and a half ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...